Journal ArticleOPEN ACCESS

Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients

Clinical Infectious Diseases (2020) 71(16) 2227-2229
DOI: 10.1093/cid/ciaa394
73Citations
Citations of this article
225Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting in various concentrations. Pharmacokinetic studies are therefore needed to define the optimal dosing regimen.

Author supplied keywords

Cite

CITATION STYLE

APA

Perinel, S., Launay, M., Botelho-Nevers, É., Diconne, É., Louf-Durier, A., Lachand, R., … Delavenne, X. (2020). Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients. Clinical Infectious Diseases, 71(16), 2227–2229. https://doi.org/10.1093/cid/ciaa394

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free